# MECHANICAL VENTILATION

## Indications

• Improve gas exchange: ↑ oxygenation, ↑ alveolar vent and/or reverse acute resp acidosis

• Relieve respiratory distress: ↓ work of breathing (can account for up to 50% of total O2 consumption), ↓ respiratory muscle fatigue

• Apnea, airway protection, pulmonary toilet

# SUPPORTIVE STRATEGIES PRIOR TO INTUB. OR AFTER EXTUB.

<table><colgroup><col> <col> <col></colgroup><tbody><tr><td colspan="3"><p><b>Oxygen Delivery Systems</b> (<span><i>Lancet</i> 2016;387:1867</span>)</p></td></tr><tr><td><p><b>System or Device</b></p></td><td><p><b>O<sub>2</sub> Flow<sup>a</sup></b></p></td><td><p><b>F<sub>i</sub>O<sub>2</sub> Range &amp; Comments</b></p></td></tr><tr><td><p>Low-flow nasal cannula</p></td><td><p>1–6</p></td><td><p>24–40%, 1L adds ~3% F<sub>i</sub>O<sub>2</sub></p></td></tr><tr><td><p>Standard face mask</p></td><td><p>5–10</p></td><td><p>35–50%, minimum 5 L/min</p></td></tr><tr><td><p>Partial rebreather mask</p></td><td><p>&gt;10</p></td><td><p>40–70%</p></td></tr><tr><td><p>Nonrebreather mask</p></td><td><p>&gt;10</p></td><td><p>60–80% (not 100% b/c air leaks)</p></td></tr><tr><td><p>Air-entrainment mask</p><p>(Venturi or Venti mask)</p></td><td><p>10–15<sup>b</sup></p></td><td><p>24–50%, F<sub>i</sub>O<sub>2</sub> stays constant</p></td></tr><tr><td><p>High-flow nasal O<sub>2</sub></p><p>(<span><i>NEJM</i> 2015;372:2185;</span></p><p><span><i>JAMA</i> 2015;313:2331 &amp; 2016;315:1354)</span></p></td><td><p>≤40</p></td><td><p>21–100%. In nonhypercapnic acute hypoxemic</p><p>Resp failure, ± ↓ intub. (espec if P<sub>a</sub>O<sub>2</sub>/F<sub>i</sub>O<sub>2</sub> ≤200) &amp; ↓ 90-d mort vs. stnd O<sub>2</sub> or NPPV.</p><p>Routine use after extub. ↓ need for reintub.</p></td></tr></tbody></table>

a L/min. b Total airflow >60L/min. (Adapted from Marino P. _The ICU Book_, 4th ed, Philadelphia: LWW, 2014:431)

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>Noninvasive Positive Pressure Ventilation (NPPV)</b> <span>(<i>NEJM</i> 2015;372:e30)</span></p></td></tr><tr><td><p><b>Indications</b> (<i>Lancet</i> 2009;374:250)</p></td><td><p><i>Clinical:</i> mod–severe dyspnea, RR &gt;24–30, signs of ↑ work of breathing, accessory muscle use, abd paradox</p><p><i>Gas exchange:</i> P<sub>a</sub>CO<sub>2</sub> &gt;45 mmHg (&amp; significantly worse than baseline), hypoxemia, P<sub>a</sub>O<sub>2</sub>/F<sub>i</sub>O<sub>2</sub> &lt;200</p></td></tr><tr><td><p><b>Contraindications</b></p><p><span><i>Crit Care Med</i> 2007;35:2402</span></p></td><td><p>Claustrophobia, poor mask fit, Δ<b>MS</b>, vomiting, <b>cannot protect airway</b>, extrapulm organ failure, HD instab, sev UGIB, ↑ secretions</p></td></tr><tr><td><p><b>Continuous positive airway pressure (CPAP)</b></p></td><td><p>≈ PEEP. Pt breathes spont at own rate while vent maintains constant positive airway pressure throughout respiratory cycle.</p><p>No limit on O<sub>2</sub> delivered (ie, can give hi-flow → F<sub>i</sub>O<sub>2</sub> ≈1.0)</p><p>Used if primary problem <b><i>hypoxemia</i></b> (eg, CHF)</p></td></tr><tr><td><p><b>Bilevel positive airway pressure (BiPAP)</b></p></td><td><p>≈ PSV + PEEP. Able to set both inspiratory (usually 8–10 cm H<sub>2</sub>O) and expiratory pressures (usually &lt;5 cm H<sub>2</sub>O).</p><p>Used if primary problem <i>hypoventilation</i>; F<sub>i</sub>O<sub>2</sub> delivery limited</p></td></tr><tr><td><p><b>Mask ventilation</b> (? helmet better; <i>JAMA</i> 2016;315:2435)</p></td><td><p>Tight-fitting mask connecting Pt to a standard ventilator</p><p>Can receive PS ~20–30 cm H<sub>2</sub>O, PEEP ~10 cm H<sub>2</sub>O, F<sub>i</sub>O<sub>2</sub> ~1.0</p><p>Used for short-term support (&lt;24 h) for a reversible process</p></td></tr><tr><td><p><b>Conditions with strong evidence</b></p><p><span><i>Lancet</i> 2000;355:1931</span></p><p><span><i>AJRCCM</i> 2006;173:164</span></p></td><td><p><b>Cardiogenic pulmonary edema:</b> may ↓ intub. &amp; mortality (<span><i>JAMA</i> 2005;294:3124; <i>Lancet</i> 2006;367:1155</span>) although recent trial (w/ high crossover) did not show any mortality benefit (<i>NEJM</i> 2008;359:142)</p><p><b>COPD exac</b> with ↑ P<sub>a</sub>CO<sub>2</sub>: ↓ intub. &amp; mort, but if pH &lt;7.3 → intubate</p><p>High-risk extub. (age &gt;65, CHF, APACHE II &gt;12): NPPV × 24 h directly after extub. → ↓ reintub. and, if P<sub>a</sub>CO<sub>2</sub> &gt;45 mmHg during SBT, ↓ mortality. Does not ∆ total # vent days (<span><i>JAMA</i> 2018;320:1881</span>).</p></td></tr><tr><td><p><span><i>JAMA</i> 2016;315:1345</span></p><p><span><i>NEJM</i> 2001;344:481</span></p></td><td><p>Hypoxemic resp failure after abdominal surgery: ↓ reintubation</p><p><b>Immunosupp</b> with infiltrates: ↓ complications &amp; mortality</p></td></tr></tbody></table>

# VENTILATOR MANAGEMENT

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>Ventilator Modes and Principles</b> (<span><i>NEJM</i> 2001;344:1986; <i>Chest</i> 2015;148:340</span>)</p></td></tr><tr><td><p><b>Cont mandatory ventilation (CMV), aka Assist control (AC)</b></p></td><td><p>Vent delivers a minimum number of supported breaths</p><p>Additional Pt-initiated breaths trigger <i>fully assisted</i> vent breaths</p><p>∴ Vent-triggered breaths identical to Pt-triggered breaths</p><p>Tachypnea → ? resp. alkalosis, breath-stacking, &amp; auto-PEEP</p><p>May be pressure targeted or volume targeted (qv)</p></td></tr><tr><td><p><b>Pressure support vent (PSV)</b></p></td><td><p>Support Pt-initiated breaths with a set inspiratory pressure &amp; PEEP</p><p>A mode of <i>partial</i> vent support because no set rate</p></td></tr><tr><td><p><b>Other</b></p></td><td><p>Synch intermittent mand. vent: deliver min # supported breaths; V<sub>T</sub> of additional Pt-initiated breaths determined by Pt’s effort</p><p>Proportional assist ventilation (PAV): delivers variable pressure to achieve targeted % of work of breathing</p></td></tr></tbody></table>

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><a id="page_2-20"></a><p><b>Volume or Pressure Targeted</b></p></td></tr><tr><td><p><b>Volume targeted</b></p></td><td><p>Vent delivers a set V<sub>T</sub>; pressures depend on airway resist. &amp; lung/CW compl.</p><p><b>Benefit:</b> ↑ control over ventilation (ideal initial ventilator setting); benefit in ALI/ARDS; easy to measure mechanics (PIP, P<sub>plat</sub>, airway resist., compl.)</p><p>Volume control (VC) ⊕: vent delivers variable pressure (depending on real- time lung compliance) to achieve set V<sub>T</sub></p></td></tr><tr><td><p><b>Pressure targeted</b></p></td><td><p>Vent delivers a fixed inspiratory pressure regardless of V<sub>T</sub></p><p>V<sub>T</sub> depends on airway resistance and lung/chest wall compliance</p><p><b>Benefit:</b> May ↑ Pt comfort (PSV) requiring less sedation</p></td></tr><tr><td><p><b>General principles</b></p></td><td><p><b>Institutional/practitioner preference</b> and <b>Pt comfort</b> usually dictate ventilator strategy; no strategy has proven superior</p><p><b>Alarms</b> can be set for ↑ volumes and ↑ airway pressures in pressure- targeted and volume-targeted strategies, respectively</p><p><b>Risks:</b> volutrauma (ie, overdistention, if set volume too high; <i>NEJM</i> 2013;369:2126), barotrauma [can happen with relatively high set volumes (espec if stiff lungs) or if pressure target set too high; key is to monitor transpulmonary pressure (difference between P<sub>plat</sub> and esophageal ≈ intrapleural), not just airway pressure]; can result in PTX, pneumomediastinum</p><p><b>Hypo-/hyperventilation:</b> need to ✔ minute vent &amp; pH/P<sub>a</sub>CO<sub>2</sub></p></td></tr></tbody></table>

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>Variables on the Ventilator</b></p></td></tr><tr><td><p><b>F<sub>i</sub>O<sub>2</sub></b></p></td><td><p>Fraction of inspired air that is oxygen</p></td></tr><tr><td><p><b>V<sub>T</sub></b> (tidal vol)</p></td><td><p>Volume of breath delivered; lung-protective ventilation: goal ≤6 ml/kg IBW</p><p>If no ARDS, similar # of vent days at higher V<sub>T</sub> <span>(<i>JAMA</i> 2018;320:1872)</span></p></td></tr><tr><td><p><b>f</b> (resp. rate)</p></td><td><p>Rate set by ventilator, f may be lower than RR if Pt triggering breaths.</p><p>Adjust to achieve desired P<sub>a</sub>CO<sub>2</sub>.</p></td></tr><tr><td><p><b>Positive end- expiratory pressure (PEEP)</b></p></td><td><p>Positive pressure applied during exhalation via resistor in exhalation port</p><p>Benefits: prevents alveolar collapse, ↓ shunt, ↑ O<sub>2</sub> via alveolar recruitment and improved compliance, allows severely obstructed Pt to initiate breath</p><p>Cardiac effects: ↓ preload by ↑ intrathoracic pressure → ↓ venous return; ↓ afterload by ↓ cardiac transmural pressure; may ↑ or ↓ CO and may ↑ or ↓ oxygen delivery based on the above</p><p>Auto-PEEP or intrinsic PEEP: inadequate exhalation time → lungs unable to completely empty before the next breath (ie, “breath stacking”); if flow at end-expiration, there must be pressure = auto-PEEP. Will ↓ preload and may ↓ CO, espec if hypovolemic</p><p>Will ↑ work of breathing as must be overcome by Pt to trigger breaths; can prevent Pt from triggering ventilator, extrinsic PEEP helps</p><p>Can be detected if end-expiratory flow ≠ 0 before next breath</p><p>Can measure by occluding expiratory port of vent at end-expiration</p><p>Can ↓ by: ↑ exp time, ↓ RR, ↓ V<sub>T</sub>, Rx bronchospasm and secretions</p></td></tr><tr><td><p><b>Inspiratory time</b></p></td><td><p>Normally I:E ratio is ~1:2; however, can alter I time (and consequently flow rate, see later); use in pressure-control mode</p></td></tr><tr><td><p><b>Inspiratory flow rates</b></p></td><td><p>↑ flow rate → ↓ I time → ↑ E time → ∴ may improve ventilation in obstructive disease, but may affect resp rate and bronchodilation/constriction</p></td></tr><tr><td><p><b>Peak inspiratory pressure (PIP)</b></p></td><td><p>Dynamic measurement during inspiration; set in pressure-targeted mode</p><p>Determined by airway resistance and lung/chest wall compliance</p><p>↑ PIP without ↑ P<sub>plat</sub> → ↑ airway resist (eg, bronchospasm, plugging)</p><p>↓ PIP → ↓ airway resistance or air leak in the system</p></td></tr><tr><td><p><b>Plateau pressure (P<sub>plat</sub></b>)</p></td><td><p>Static measurement at the end of inspiration when there is no flow</p><p>Determined by resp system compliance (resist. not a factor since ∅ flow)</p><p>↑ P<sub>plat</sub> → ↓ lung or chest wall compliance (eg, PTX, pulmonary edema, pneumonia, atelectasis), ↑ PEEP or auto-PEEP</p><p>P<sub>plat</sub> &lt;30 cm H<sub>2</sub>O ↓ barotrauma (↓ V<sub>T</sub>, ↓ PEEP or ↑ compl [eg, by diuresis])</p></td></tr></tbody></table>

## Tailoring the ventilator settings

* * To improve oxygenation: options include ↑ FiO2, ↑ PEEP
* SaO2 88–92% acceptable (_AJRCCM_ 2016;193:43), do not exceed 96% (_BMJ_ 2018;363:k4169)
* First, ↑ FiO2. If >0.6 and oxygenation remains suboptimal, then try ↑ PEEP:
* If ↑ PaO2/FiO2 _and_ Pplat stable, suggests recruitable lung (ie, atelectasis). If PEEP 20 & FiO2 1.0 and oxygenation remains suboptimal, consider rescue/expt strategies (see “ARDS”).
* If ↑ PEEP yields no Δ _or_ ↓ PaO2/FiO2 _or_ ↑ PaCO2, suggests additional lung _not_ recruitable and instead overdistending lung → ↑ shunt & dead space; ∴ ↓ PEEP
• To improve ventilation: ↑ VT or inspiratory pressure, ↑ RR (may need to ↓ I time). Nb, tolerate ↑ PaCO2 (permissive hypercapnia) in ALI/ARDS (qv) as long as pH >7.2.

## Acute ventilatory deterioration (usually ↑ PIP)

• Response to ↑ PIP: disconnect Pt from vent, bag, auscultate, suction, ✔ CXR & ABG

### Figure 2-7 Approach to acute ventilatory deterioration

![](https://i.imgur.com/qRTJIiN.jpg)

(Adapted from Marino PL. _The ICU Book_, 4th ed., Philadelphia: LWW, 2014)

## Liberating from the ventilator (_NEJM_ 2012;367:2233; _Lancet_ 2016;387:1856)

• Perform daily assessment of readiness for spontaneous breathing trial (SBT)

• 臨床screening criteria: VS stable, minimal secretions, adequate cough, cause of respiratory failure or previously failed SBT reversed

• Vent parameters: PaO2/FiO2 >200, PEEP ≤5, f/VT <105, VE <12 L/min, VC >10 mL/kg; rapid shallow breathing index (f/VT) >105 predicts failure, NPV 0.95 (_NEJM_ 1991;324:1445)

• Daily awakening trial (d/c all sedation; _Lancet_ 2008;371:126): open eyes & without: agitation, RR >35, SaO2 <88%, resp distress or arrhythmias (if fail, restart sedation at 1/2 prior dose)

• SBT = CPAP × 30 min superior to T-piece × 120 min (_JAMA_ 2019;321:2175)

failure if: deteriorating ABGs, ↑ RR, ↑ or ↓ HR, ↑ or ↓ BP, diaphoresis, anxiety

• Tolerate SBT → extubation. Fail SBT → ? cause → work to correct → retry SBT qd

• In high-risk 病人, extubation to either NPPV or high-flow O2 equivalent (_JAMA_ 2016;316:1565)

• ? acetazolamide in 病人 with COPD & metabolic alkalosis (_JAMA_ 2016;315:480)

## Complications

• Oxygen toxicity (theoretical); proportional to duration + degree of ↑ oxygen (FiO2 >0.6)

• Ventilator-induced lung injury (see “ARDS”)

• Ventilator-associated pneumonia (~1%/d, mortality rate ~30%)

typical pathogens: MRSA, _Pseudomonas_, _Acinetobacter_ and _Enterobacter_ species

preventive strategies (_AJRCCM_ 2005;171:388): wash hands, HOB elevated, non-nasal intub., enteral nutrition rather than TPN?, routine suction of subglottic secretions, avoid unnecessary 抗生素 & transfusions; routine oral antiseptic controversial

• Stress ulcers/GIB: prophylaxis with PPI ↓ GIB, but no Δ in overall course (_NEJM_ 2018;379:2199)

• Laryngeal

edema: for 病人 vent >36 h; ? predicted by ⊕ cuff leak test. Methylprednisolone 20 mg IV q4h starting 12 h pre-extub. → ↓↓ edema and 50% ↓ in reintubation (_Lancet_ 2007;369:1003).

ulceration: consider _tracheostomy_ for 病人 in whom expect >14 d of mech vent → ↓ duration mech vent, ↓ # ICU days (_BMJ_ 2005;330:1243); no benefit to performing at ~1 wk vs. waiting until ~2 wk (_JAMA_ 2010;303:1483)

• Malnutrition (for all critically ill 病人): _enteral nutrition_ initiated early is safe but not necessary (_JAMA_ 2012;307:795), but bolus may ↑ risk of VAP & _C diff._ (_JPEN_ 2002;26:174); no clear benefit to ✔ing gastric residuals (_JAMA_ 2013;309:249); permissive enteral underfeeding (~1/2 of calculated caloric req) & standard enteral feeding with similar outcomes (_NEJM_ 2015;372:2398); _parenteral nutrition_ should be delayed until after day 8 to ↓ risk of infections, cholestasis, RRT, ventilator days (_NEJM_ 2011;365:506)

• Oversedation/delirium: BDZs and polypharmacy are risk factors

propofol: HoTN in ~25%; _propofol infusion syndrome_ (PRIS) ? espec with high (>5 mg/kg/h) & prolonged (>48 h) infusions & concom vasopressors → ↑ AG, cardiac dysfxn, rhabdomyolysis, ↑ triglycerides, & renal failure (_Crit Care_ 2009;13:R169)

dexmedetomidine: no clear benefit on vent-free days (_JAMA_ 2016;315:1460 & 2017;317:1321); dosen't work as sole agent, but spares use of other (_NEJM_ 2019;380:2506)
